PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Goserelin acetate - Uterine fibroids

PAD Profile : Goserelin acetate - Uterine fibroids

Brand Names Include :
Zoladex

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Injection
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) agreed the following traffic light status for treating menorrhagia associated with fibroids:

 GREEN traffic light status

  • Tranexamic acid tablets
  • Norethisterone
  • Combined Hormonal Contraception
  • Levonorgestrel intrauterine system (LNG-IUS) - Benilexa, levosert & Mirena

RED traffic light status

GnRH/LHRH analogues

  • Triptorelin (Decapeptyl SR® 3.75mg)
  • Leuprorelin (Prostap SR DCS®) 3.75mg
  • Gosereline acetate (Zoladex® 3.6mg)

Associated BNF Codes

08. Malignant Disease and Immunosuppression
08.03.04. Hormone antagonists
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More